• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体(PPARs):脂肪酸感应器调控代谢。

PPARs: fatty acid sensors controlling metabolism.

机构信息

University of Southern Denmark, Department of Biochemistry and Molecular Biology, Campusvej 55, DK-5230, Odense M, Denmark.

出版信息

Semin Cell Dev Biol. 2012 Aug;23(6):631-9. doi: 10.1016/j.semcdb.2012.01.003. Epub 2012 Jan 18.

DOI:10.1016/j.semcdb.2012.01.003
PMID:22273692
Abstract

The peroxisome proliferator activated receptors (PPARs) are nuclear receptors that play key roles in the regulation of lipid metabolism, inflammation, cellular growth, and differentiation. The receptors bind and are activated by a broad range of fatty acids and fatty acid derivatives and they thereby serve as major transcriptional sensors of fatty acids. Here we review the function, regulation, and mechanism of the different PPAR subtypes with special emphasis on their role in the regulation of lipid metabolism.

摘要

过氧化物酶体增殖物激活受体 (PPARs) 是核受体,在脂质代谢、炎症、细胞生长和分化的调节中发挥关键作用。这些受体结合并被广泛的脂肪酸和脂肪酸衍生物激活,因此它们是脂肪酸的主要转录传感器。本文综述了不同 PPAR 亚型的功能、调节和机制,特别强调了它们在脂质代谢调节中的作用。

相似文献

1
PPARs: fatty acid sensors controlling metabolism.过氧化物酶体增殖物激活受体(PPARs):脂肪酸感应器调控代谢。
Semin Cell Dev Biol. 2012 Aug;23(6):631-9. doi: 10.1016/j.semcdb.2012.01.003. Epub 2012 Jan 18.
2
[PPARs-mediated intracellular signal transduction].过氧化物酶体增殖物激活受体介导的细胞内信号转导
Nihon Rinsho. 2005 Apr;63(4):565-71.
3
The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.过氧化物酶体增殖物激活受体N端结构域控制同种型选择性基因表达和脂肪生成。
Mol Endocrinol. 2006 Jun;20(6):1261-75. doi: 10.1210/me.2006-0025. Epub 2006 Mar 23.
4
An overview on biological mechanisms of PPARs.过氧化物酶体增殖物激活受体(PPARs)的生物学机制概述。
Pharmacol Res. 2005 Feb;51(2):85-94. doi: 10.1016/j.phrs.2004.07.012.
5
[The structures and functions of peroxisome proliferator-activated receptors (PPARs)].[过氧化物酶体增殖物激活受体(PPARs)的结构与功能]
Nihon Rinsho. 2005 Apr;63(4):557-64.
6
Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors.硝酰基脂肪酸作为新型亲电配体用于过氧化物酶体增殖物激活受体。
Free Radic Biol Med. 2012 Nov 1;53(9):1654-63. doi: 10.1016/j.freeradbiomed.2012.08.572. Epub 2012 Aug 30.
7
[Nuclear Receptor PPARs and magnesium].[核受体过氧化物酶体增殖物激活受体与镁]
Clin Calcium. 2005 Nov;15(11):52-64.
8
Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives.过氧化物酶体增殖物激活受体作为脂肪酸及其衍生物的传感器。
Cell Mol Life Sci. 2007 Oct;64(19-20):2459-64. doi: 10.1007/s00018-007-7278-5.
9
[PPARs target genes].[过氧化物酶体增殖物激活受体靶基因]
Nihon Rinsho. 2005 Apr;63(4):573-7.
10
Peroxisome proliferator-activated receptors and the metabolic syndrome.过氧化物酶体增殖物激活受体与代谢综合征
Physiol Behav. 2008 May 23;94(2):187-97. doi: 10.1016/j.physbeh.2007.11.053. Epub 2007 Dec 7.

引用本文的文献

1
Macrophage-derived VISTA engages with LRIG1 and hinders gut epithelial repair in colitis.巨噬细胞衍生的VISTA与LRIG1相互作用并阻碍结肠炎中肠道上皮的修复。
Cell Mol Immunol. 2025 Aug 29. doi: 10.1038/s41423-025-01338-y.
2
Effect of ammonium fluoride as a mobile phase additive on quantitativity of fatty acids in electrospray ionization-liquid chromatography-tandem mass spectrometry.氟化铵作为流动相添加剂对电喷雾电离-液相色谱-串联质谱法中脂肪酸定量的影响
Anal Sci. 2025 Aug 18. doi: 10.1007/s44211-025-00832-7.
3
Sea buckthorn flavonoids and their derivatives: potential natural compounds for the treatment of diabetic cardiomyopathy.
沙棘黄酮及其衍生物:治疗糖尿病性心肌病的潜在天然化合物。
Front Pharmacol. 2025 Jul 17;16:1599756. doi: 10.3389/fphar.2025.1599756. eCollection 2025.
4
Metagenomic and Metabolomic Profiling Reveals the Impact of High-Fat Diet on Malignant Pleural Effusion.宏基因组学和代谢组学分析揭示高脂饮食对恶性胸腔积液的影响。
Thorac Cancer. 2025 Jul;16(14):e70126. doi: 10.1111/1759-7714.70126.
5
The role and mechanism of fatty acid oxidation in cancer drug resistance.脂肪酸氧化在癌症耐药中的作用及机制。
Cell Death Discov. 2025 Jun 13;11(1):277. doi: 10.1038/s41420-025-02554-1.
6
Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis.小鼠棕色脂肪细胞中PPARα的缺失会增加其从头脂肪生成。
Mol Metab. 2025 Aug;98:102184. doi: 10.1016/j.molmet.2025.102184. Epub 2025 Jun 10.
7
Rational molecular design of novel class-III peptidic antagonists to competitively disrupt human PPARδ self-binding peptide.新型III类肽拮抗剂的合理分子设计,以竞争性破坏人PPARδ自结合肽。
J Comput Aided Mol Des. 2025 Apr 24;39(1):18. doi: 10.1007/s10822-025-00594-4.
8
The role of Perilipin 5 in pathological myocardial remodeling.脂联素5在病理性心肌重塑中的作用。
Front Pharmacol. 2025 Mar 17;16:1526494. doi: 10.3389/fphar.2025.1526494. eCollection 2025.
9
Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation.索拉非尼通过促进PPARα介导的脂肪酸氧化增强了肝癌中髓源性抑制细胞的功能。
Mol Cancer. 2025 Jan 28;24(1):34. doi: 10.1186/s12943-025-02238-5.
10
Potential therapeutic strategies for MASH: from preclinical to clinical development.非酒精性脂肪性肝炎的潜在治疗策略:从临床前到临床开发
Life Metab. 2024 Jul 6;3(5):loae029. doi: 10.1093/lifemeta/loae029. eCollection 2024 Oct.